Effects of Social Support Source and Effectiveness on Stress Buffering After Stem Cell Transplant.


Journal

International journal of behavioral medicine
ISSN: 1532-7558
Titre abrégé: Int J Behav Med
Pays: England
ID NLM: 9421097

Informations de publication

Date de publication:
Aug 2019
Historique:
pubmed: 30 5 2019
medline: 5 11 2019
entrez: 30 5 2019
Statut: ppublish

Résumé

This study used the social support effectiveness framework to examine whether effective social support buffered the relationship between stressful life events and distress among hematopoietic stem cell transplant (HSCT) survivors and whether that buffering effect depended on the type of caregiver who provided it (partner versus non-partner caregivers). A total of 275 HSCT survivors completed measures of the effectiveness of their caregiver's support-social support effectiveness (SSE)-distress, and stressful life events. Hierarchical linear regression was used to analyze a three-way interaction between stressful life events, caregiver SSE, and caregiver type on distress. After controlling for covariates, the three-way interaction of stressful life events, caregiver SSE, and caregiver type was significant (b = - 0.21, SE = 0.00, p < 0.001). Among partnered survivors, more stressful life events were associated with greater distress (B = 0.03, SE = 0.01, p = 0.045) when caregiver SSE was low. There was no association between stressful life events and distress when caregiver SSE was average (B = 0.01, SE = 0.01, p = 0.50) or high (B = - 0.01, SE = 0.02, p = 0.61). Among non-partnered survivors, there was a positive association between stressful life events and distress regardless of caregiver SSE. Average or highly effective caregiver support buffered effects of stressful life events on distress among partnered survivors. There was no evidence that support at any level of effectiveness buffered stressful life events among non-partnered survivors. Findings highlight the importance of measuring social support effectiveness and source of support among HSCT survivors.

Sections du résumé

BACKGROUND BACKGROUND
This study used the social support effectiveness framework to examine whether effective social support buffered the relationship between stressful life events and distress among hematopoietic stem cell transplant (HSCT) survivors and whether that buffering effect depended on the type of caregiver who provided it (partner versus non-partner caregivers).
METHODS METHODS
A total of 275 HSCT survivors completed measures of the effectiveness of their caregiver's support-social support effectiveness (SSE)-distress, and stressful life events. Hierarchical linear regression was used to analyze a three-way interaction between stressful life events, caregiver SSE, and caregiver type on distress.
RESULTS RESULTS
After controlling for covariates, the three-way interaction of stressful life events, caregiver SSE, and caregiver type was significant (b = - 0.21, SE = 0.00, p < 0.001). Among partnered survivors, more stressful life events were associated with greater distress (B = 0.03, SE = 0.01, p = 0.045) when caregiver SSE was low. There was no association between stressful life events and distress when caregiver SSE was average (B = 0.01, SE = 0.01, p = 0.50) or high (B = - 0.01, SE = 0.02, p = 0.61). Among non-partnered survivors, there was a positive association between stressful life events and distress regardless of caregiver SSE.
CONCLUSIONS CONCLUSIONS
Average or highly effective caregiver support buffered effects of stressful life events on distress among partnered survivors. There was no evidence that support at any level of effectiveness buffered stressful life events among non-partnered survivors. Findings highlight the importance of measuring social support effectiveness and source of support among HSCT survivors.

Identifiants

pubmed: 31140146
doi: 10.1007/s12529-019-09787-2
pii: 10.1007/s12529-019-09787-2
pmc: PMC6839542
mid: NIHMS1053252
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

391-400

Subventions

Organisme : NCI NIH HHS
ID : K07 CA184145
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA057726
Pays : United States
Organisme : NCI NIH HHS
ID : K07CA184145
Pays : United States
Organisme : American Cancer Society
ID : RSGPB-07-285-01-CPPB

Références

Psychosom Med. 2013 Nov-Dec;75(9):856-62
pubmed: 24163383
Am J Community Psychol. 1986 Apr;14(2):177-93
pubmed: 3717088
Pers Relatsh. 2004 Mar;11(1):23-40
pubmed: 16946802
J Fam Psychol. 2014 Dec;28(6):832-43
pubmed: 25243576
Perspect Psychol Sci. 2009 May;4(3):236-55
pubmed: 26158961
Support Care Cancer. 2011 Sep;19(9):1357-65
pubmed: 20661753
J Behav Med. 2006 Jun;29(3):291-8
pubmed: 16565785
J Pers Soc Psychol. 2007 Mar;92(3):458-75
pubmed: 17352603
Psychol Sci. 2015 Feb;26(2):135-47
pubmed: 25526910
J Consult Clin Psychol. 2011 Feb;79(1):64-74
pubmed: 21261435
J Health Soc Behav. 2011 Jun;52(2):145-61
pubmed: 21673143
J Consult Clin Psychol. 1986 Aug;54(4):416-23
pubmed: 3745593
Br J Health Psychol. 2014 Sep;19(3):486-508
pubmed: 23621677
J Appl Psychol. 2003 Apr;88(2):324-31
pubmed: 12731716
Bone Marrow Transplant. 2009 Jun;43(12):959-66
pubmed: 19104493
Am J Community Psychol. 1988 Oct;16(5):685-700
pubmed: 3218638
Bone Marrow Transplant. 2005 Jan;35(1):77-83
pubmed: 15502851
Bone Marrow Transplant. 2012 Apr;47(4):473-82
pubmed: 21602898
J Nerv Ment Dis. 1977 Dec;165(6):403-17
pubmed: 591939
J Pers Soc Psychol. 2008 May;94(5):824-38
pubmed: 18444741
J Pediatr Adolesc Gynecol. 2012 Jun;25(3):201-7
pubmed: 22578481
Health Psychol. 2014 Dec;33(12):1541-51
pubmed: 24274798
Psychooncology. 2016 Jun;25(6):684-90
pubmed: 26126444
J Am Board Fam Pract. 2001 Mar-Apr;14(2):95-106
pubmed: 11314930
Am J Community Psychol. 1994 Jun;22(3):319-39
pubmed: 7879745
Soc Sci Med. 1988;27(4):385-92
pubmed: 3175721
Gynecol Oncol. 2006 Mar;100(3):479-86
pubmed: 16185753
J Trauma Stress. 2012 Dec;25(6):721-7
pubmed: 23184348
Psychol Bull. 1985 Sep;98(2):310-57
pubmed: 3901065
Psychosom Med. 1979 May;41(3):209-18
pubmed: 472086
J Clin Oncol. 1993 Mar;11(3):570-9
pubmed: 8445433
West J Nurs Res. 2002 Nov;24(7):815-29
pubmed: 12428897
Am J Community Psychol. 1982 Feb;10(1):65-80
pubmed: 7102614
J Consult Clin Psychol. 1978 Oct;46(5):932-46
pubmed: 701572
Med Care. 2002 Sep;40(9):771-81
pubmed: 12218768
Annu Rev Psychol. 2003;54:351-75
pubmed: 12415073
Bone Marrow Transplant. 2012 Jun;47(6):757-69
pubmed: 21725373
Am J Community Psychol. 2002 Oct;30(5):637-54
pubmed: 12188054
Palliat Support Care. 2015 Dec;13(6):1735-44
pubmed: 26062657
JAMA. 2004 May 19;291(19):2335-43
pubmed: 15150205
J Stud Alcohol. 2000 May;61(3):447-9
pubmed: 10807217
Bone Marrow Transplant. 1997 Feb;19(4):357-68
pubmed: 9051246
Psychooncology. 2007 Sep;16(9):821-33
pubmed: 17219398

Auteurs

Marjorie Margolis (M)

University of North Carolina Gillings School of Global Public Health, 170 Rosenau Hall #7400, 135 Dauer Drive, Chapel Hill, NC, 27599-7400, USA. Marjorie_margolis@med.unc.edu.
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, 450 West Drive, Chapel Hill, NC, 27599-7440, USA. Marjorie_margolis@med.unc.edu.

Jane Austin (J)

William Paterson University, Wayne, NJ, USA.

Lisa Wu (L)

Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Heiddis Valdimarsdottir (H)

University of Reykjavik, Reykjavik, Iceland.
Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Annette L Stanton (AL)

University of California, Los Angeles, CA, USA.

Scott D Rowley (SD)

John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA.
Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.

Pashna M Munshi (PM)

Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.

Christine Rini (C)

John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA.
Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH